Home
Mail
Search
News
Finance
Sport
TV
Lifestyle
Entertainment
Mobile
Horoscopes
More
Yahoo
Mail
Watchlists
My Portfolios
Market Data
Latest News
Industries
Personal Finance
Currency Convertor
Video
New Zealand markets closed
NZX 50
11,938.08
+64.04
(+0.54%)
NZD/USD
0.6012
+0.0049
(+0.83%)
NZD/EUR
0.5579
+0.0023
(+0.42%)
ALL ORDS
7,897.50
+48.10
(+0.61%)
ASX 200
7,629.00
+42.00
(+0.55%)
OIL
77.99
-0.96
(-1.22%)
AngioDynamics, Inc. (ANGO)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.27
+0.19
(+3.13%)
At close: 04:00PM EDT
6.29
+0.02
(+0.32%)
After hours:
04:38PM EDT
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/05/2023
31/05/2022
31/05/2021
31/05/2020
Total revenue
324,008
338,752
316,219
291,010
264,157
Cost of revenue
161,466
164,506
150,487
134,222
113,885
Gross profit
162,542
174,246
165,732
156,788
150,272
Operating expenses
Research development
32,648
29,883
30,739
36,390
29,682
Selling general and administrative
145,481
144,252
133,752
117,224
116,506
Total operating expenses
193,009
192,925
183,949
171,750
164,309
Operating income or loss
-30,467
-18,679
-18,217
-14,962
-14,037
Interest expense
-
2,702
688
861
907
Total other income/expenses net
-169,041
-33,056
-11,044
-20,229
-153,191
Income before tax
-199,362
-54,437
-29,949
-36,052
-168,135
Income tax expense
-6,995
-1,995
-3,402
-4,504
-1,348
Income from continuing operations
-192,367
-52,442
-26,547
-31,548
-166,787
Net income
-192,367
-52,442
-26,547
-31,548
-166,787
Net income available to common shareholders
-192,367
-52,442
-26,547
-31,548
-166,787
Basic EPS
-0.36
-1.33
-0.68
-0.82
-4.39
Diluted EPS
-0.36
-1.33
-0.68
-0.82
-4.39
Basic average shares
39,798
39,480
39,009
38,342
37,961
Diluted average shares
39,835
39,480
39,009
38,342
37,961
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.